Predict your next investment

RISK & SECURITY | Security Products / Security & Monitoring Equipment
inclinix.com

See what CB Insights has to offer

Founded Year

1999

Stage

Merger | Merged

Total Raised

$10M

About Inclinix

Inclinix aims to provide terror agent detection and communication technology using its patent-pending Expert System Platform. ThreatScreen identifies possible exposure, aims to provide early treatment options, and tracks victims, producing common threads of signs and symptoms that may indicate a terrorist attack or emerging contagious diseases. ThreatScreen aims to bring victim screening, treatment communication, and notification technology to federal, local, and state agencies, as well as military installations and other homeland security applications.In June 2012, Inclinix merged with PMG Research, funded by a consortium of investors including Frontier Capital.

Inclinix Headquarter Location

3534 S College Road Suite F

Wilmington, North Carolina, 28412,

United States

888-898-7425

Latest Inclinix News

TKL Research Hires New Vice President of Global Business Development

Jun 2, 2015

Alkermes Appoints Senior Vice President of Research, Pharmaceutical and Nonclinical Development “Jeff is a proven leader in business development and clinical operations,” said Dr. Robert Reardon , Ph.D., Chief Operating Officer at TKL. “This unique combination gives him an exceptional ability to understand client needs and will help us tailor our offerings for rapid enrollment and high-quality clinical research.” Bagshaw previously served as Chief Operating Officer at Inclinix, Inc., where he was responsible for leading global operations, strategic partnership development and clinical research services. During his tenure at Inclinix, he held various leadership roles in medical marketing and compliance, medical support services and business development. In addition to Inclinix, Bagshaw has more than 25 years of experience in the pharmaceutical, biotechnology, medical device and applied genomic industries, and he has been responsible for the clinical development and marketing of products across numerous therapeutic areas. His experience includes leadership roles at Hoffmann-La Roche, Bristol-Myers Squibb and Exact Sciences. Get to know TKL’s leadership team and learn about the company’s capabilities by visiting TKLResearch.com . About TKL Research Headquartered in Rochelle Park, New Jersey, TKL Research is a full-service international clinical research organization (CRO) serving the pharmaceutical , biotechnology , medical device and consumer healthcare industries. TKL Research provides comprehensive clinical trial management services for Phase I-IV clinical research studies, including an inpatient Phase I facility and outpatient specialized research clinics while delivering to our clients a competitive edge with accelerated enrollment . View source version on businesswire.com: http://www.businesswire.com/news/home/20150602005414/en/ TKL Research, Inc. Lee Rush Schwartz, 201-587-0500 ext. 5118 Marketing Manager

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.